The Cooper Companies ($COO) reported its Q1 2025 financial results, revealing an adjusted earnings per share (EPS) of $0.92, surpassing analysts' expectations of $0.91. However, the company's revenue for the quarter was $964.7 million, falling short of the anticipated $978.1 million. The net income for the period was reported at $104.3 million. The company noted a strong organic revenue growth of 5%, with CooperVision's revenue increasing by 6% and CooperSurgical's by 2%. Additionally, the gross margin expanded to 69% due to efficiency gains. The guidance for CooperVision's revenue remains unchanged at between $2.733 billion and $2.786 billion, reflecting an expected organic growth of 6.5% to 8.5%, while CooperSurgical's revenue guidance is held steady at $1.347 billion to $1.372 billion, with an anticipated organic growth of 4% to 6%.